Interleukin inhibitors

Important note: Before prescribing, consult full prescribing information.

Presentation: Secukinumab. Powder for solution for subcutaneous injection containing 150 mg of secukinumab.

Indications:

• Plaque psoriasis: Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

• Psoriatic arthritis: Treatment of active psoriatic arthritis in adult patients, alone or in combination with methotrexate (MTX), when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.

• Axial spondyloarthritis (axSpA) with or without radiographic damage:

  • Ankylosing  spondylitis(AS)  /  axSpA  with  radiographic  damage: Treatment  of  active ankylosing spondylitis in adults who have responded inadequately to conventional therapy.

  • Non-radiographic   axial   spondyloarthritis   (nr-axSpA)/axSpA   without   radiographic damage: Treatment  of adult  patients with  active  non-radiographic axial  spondyloarthritis with objective signs of inflammation.

Reference: Scapho BSS Sept 2019

Full Prescribing Information available upon request